| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/13/2013 | CN102921007A Method and reagent used for controlling insulin resistance and diabetes mellitus |
| 02/13/2013 | CN102921003A Stabilized immune modulatory RNA (SIMRA) compounds |
| 02/13/2013 | CN102921000A Application of acetylcholinesterase as nuclease |
| 02/13/2013 | CN102920996A Impaired wound healing compositions and treatments |
| 02/13/2013 | CN102920649A Drug-loading nano-micelles, and preparation method and application thereof |
| 02/13/2013 | CN102309762B Preparation method for lactosaminated carboxymethyl chitosan magnetic nano-particle gene vector |
| 02/13/2013 | CN101993498B Adenovirus vector avian influenza recombinant vaccine |
| 02/13/2013 | CN101495157B Disease treating method |
| 02/12/2013 | US8372968 RNA interference mediating small RNA molecules |
| 02/12/2013 | US8372819 Methods and compositions for targeting skip |
| 02/12/2013 | US8372622 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/12/2013 | US8372402 Mammalian receptor proteins DCRS5; methods of treatment |
| 02/12/2013 | US8372390 Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN |
| 02/12/2013 | CA2493471C Compounds binding to p-selectin |
| 02/12/2013 | CA2492089C Delivery system for pharmaceutical agents |
| 02/12/2013 | CA2419529C Diagnosis and treatment of tumor-suppressor associated disorders |
| 02/12/2013 | CA2388450C Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 02/12/2013 | CA2382303C Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 02/12/2013 | CA2359650C Pharmaceutical preparations and methods for inhibiting tumors |
| 02/12/2013 | CA2304350C Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/07/2013 | WO2013019923A2 Methods for detecting progenitor cells and uses thereof |
| 02/07/2013 | WO2013019623A2 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 02/07/2013 | WO2013019615A2 Switch costimulatory receptors |
| 02/07/2013 | WO2013019603A2 Linear expression cassettes and uses thereof |
| 02/07/2013 | WO2013018892A1 Drug composition for cancer treatment and/or prevention |
| 02/07/2013 | WO2012145624A3 Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies |
| 02/07/2013 | WO2011085063A9 Immune modulators relating to foxo3a |
| 02/07/2013 | US20130035371 Lipid formulated dsrna targeting the pcsk9 gene |
| 02/07/2013 | US20130035282 Metabolic and cardioprotection by the myokine follistatin-like 1 polypeptide |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130034610 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| 02/07/2013 | US20130034538 Reverse hexagonal mesophases (hii) and uses thereof |
| 02/07/2013 | US20130034523 Use of sdf-1 to mitigate scar formation |
| 02/07/2013 | DE102011118024A1 New procaspase 1 expression inhibitor, useful for preventing and/or treating inflammatory diseases, which are autoinflammatory diseases |
| 02/07/2013 | CA2844038A1 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 02/07/2013 | CA2843636A1 Methods and compositions for modulating the innate immune response and/or myogenesis in a mammalian subject |
| 02/06/2013 | EP2553106A2 Pharmacologically induced transgene ablation system |
| 02/06/2013 | EP2553098A2 Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3 |
| 02/06/2013 | EP2552490A1 Ectodomains of influenza matrix 2 protein, expression system, and uses thereof |
| 02/06/2013 | EP2552473A2 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain |
| 02/06/2013 | EP2552460A1 Polymers for delivering molecules of interest |
| 02/06/2013 | EP2552456A1 Sirna therapy for transthyretin (ttr) related ocular amyloidosis |
| 02/06/2013 | EP2552455A2 Transcription factor decoys |
| 02/06/2013 | EP2206781A9 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 02/06/2013 | CN102918156A Single-strand nucleic acid molecule for controlling gene expression |
| 02/06/2013 | CN102911944A Amphioxus intracellular signal transduction protein as well as expression genes and application thereof |
| 02/06/2013 | CN102911940A Small ribonucleic acid interference molecule for specifically inhibiting NK (Natural Killer) cell receptor KIR3DL1 and application of small ribonucleic acid interference molecule |
| 02/06/2013 | CN102911938A siRNA (si Ribonucleic Acid) sequence for targeted restrain of POLD1 genetic expression |
| 02/06/2013 | CN102911267A TB/HIV (tuberculosis/human immunodeficiency virus) antigen peptide bispecific TCR (T cell receptor) as well recombinant retroviral vector and application thereof |
| 02/06/2013 | CN102911261A Agrocybe aegerita lectin AAL-2 and coding gene thereof, preparation method and application thereof |
| 02/06/2013 | CN102908631A Function of actin 84 lysine monomethylation in cytokinesis and cell proliferation as well as application thereof to drug development |
| 02/06/2013 | CN102908630A 6-modified bicyclic nucleic acid analogs |
| 02/06/2013 | CN102908622A Application of 5-LO (lipoxygenase) inhibitor for treatment of malignant tumor in blood system |
| 02/06/2013 | CN102908621A New application of miRNAs for regulating insulin sensitivity as target |
| 02/06/2013 | CN102908315A Chitosan (CS) nanoparticle delivery system of small molecular interfering ribonucleic acid and preparation method thereof |
| 02/06/2013 | CN102268456B Her-2/neu recombinant adeno-associated virus vector and construction method as well as application thereof |
| 02/06/2013 | CN101816783B Recombinant Mycobacterium smegmatis vaccine expressing HBHA-IL-12 fusion protein |
| 02/06/2013 | CN101314775B RNA disturbance target point capable of being used for treating AIDS |
| 02/06/2013 | CN101270363B DNA vaccine carrier of single-chain RNA expression with immune activation function and uses thereof |
| 02/05/2013 | US8367816 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase A2 induction |
| 02/05/2013 | US8367633 Methods of treating B-cell cancers |
| 02/05/2013 | US8367631 Pharmaceutical composition which improves in vivo gene transfer |
| 02/05/2013 | US8367629 MCP-1 binding nucleic acids and use thereof |
| 02/05/2013 | US8367626 Elastin-like polymer delivery vehicles |
| 02/05/2013 | US8367402 Extranuclear RNA splicing in neuronal dendrites |
| 02/05/2013 | US8367401 Replication competent hepatitis C virus and methods of use |
| 02/05/2013 | US8367075 Synergistic combination and method thereof |
| 02/05/2013 | US8367070 Modified surface antigen |
| 02/05/2013 | US8367068 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/05/2013 | US8367055 Immunogenic compositions against tuberculosis |
| 02/05/2013 | CA2521464C Irna conjugates |
| 02/05/2013 | CA2501719C Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 02/05/2013 | CA2489174C Rna-interference by single-stranded rna molecules |
| 02/05/2013 | CA2443275C Improved gene expression |
| 02/05/2013 | CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 02/05/2013 | CA2299119C A method of stabilizing and/or isolating nucleic acids |
| 01/31/2013 | WO2013016465A1 Target of the phosphoinositide 3-kinase pathway |
| 01/31/2013 | WO2013016446A2 Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (cftr) gene |
| 01/31/2013 | WO2013016434A1 Compositions and methods of treating head and neck cancer |
| 01/31/2013 | WO2013016352A1 Recombinant virus products and methods for inhibition of expression of dux4 |
| 01/31/2013 | WO2013016057A1 Poly(ornithine) homopolymers for the delivery of oligonucleotides |
| 01/31/2013 | WO2013015744A1 Mixed lineage leukemia 5 isoform is a potential biomarker and therapeutic target for hpv-associated cervical cancer |
| 01/31/2013 | WO2013015586A2 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 01/31/2013 | WO2013015563A2 Electro-microneedle integrated body for in-situ cutaneous gene transfer and method of manufacturing same |
| 01/31/2013 | WO2013015152A1 TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION |
| 01/31/2013 | WO2012170945A3 Methods for modulating kallikrein (klkb1) expression |
| 01/31/2013 | WO2012170125A3 Algal produced malarial transmission blocking vaccines |
| 01/31/2013 | WO2012159052A3 Targeted delivery of proteins across the blood brain barrier |
| 01/31/2013 | WO2012154698A3 Method to improve antiviral activity of nucleotide analogue drugs |
| 01/31/2013 | WO2012116210A3 Peptide for the induction of immune tolerance as treatment for systemic lupus erythematosus |
| 01/31/2013 | WO2012112984A3 Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug related applications |
| 01/31/2013 | WO2012037043A9 Treatment of autoimmune inflammation using mir-155 |
| 01/31/2013 | US20130030040 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions |
| 01/31/2013 | US20130028978 Compositions and methods for wound treatment |
| 01/31/2013 | US20130028910 Hmg1 antibody for treating inflammatory conditions |
| 01/31/2013 | US20130028901 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 01/31/2013 | US20130028868 Clinical applications of a recombinant human endostatin adenovirus (e10a) injection |
| 01/31/2013 | US20130028863 Promyelocytic leukemia protein as a redox sensor |
| 01/31/2013 | CA2842580A1 Technique for cleaving out part of poly(a) chain and/or 3'-terminal sequence of mrna to inhibit translation reaction |
| 01/30/2013 | EP2550976A2 Modulator compounds of the drug resistance in epithelial tumour cells |